216 related articles for article (PubMed ID: 33152351)
1. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
3. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
Shan X; Gegentuya ; Wang J; Feng H; Zhang Z; Zheng Q; Zhang Q; Yang K; Wang J; Xu L
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C1058-C1072. PubMed ID: 37661916
[TBL] [Abstract][Full Text] [Related]
4. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.
Price LC; Shao D; Meng C; Perros F; Garfield BE; Zhu J; Montani D; Dorfmuller P; Humbert M; Adcock IM; Wort SJ
Respir Res; 2015 Sep; 16(1):114. PubMed ID: 26382031
[TBL] [Abstract][Full Text] [Related]
6. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway.
Liu YY; Zhang WY; Wang CG; Huang JA; Jiang JH; Zeng DX
Microvasc Res; 2020 Jul; 130():103988. PubMed ID: 32057731
[TBL] [Abstract][Full Text] [Related]
9. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
10. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
[TBL] [Abstract][Full Text] [Related]
11. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
[TBL] [Abstract][Full Text] [Related]
12. Xbp1s-Ddit3 promotes MCT-induced pulmonary hypertension.
Jiang H; Ding D; He Y; Li X; Xu Y; Liu X
Clin Sci (Lond); 2021 Nov; 135(21):2467-2481. PubMed ID: 34676402
[TBL] [Abstract][Full Text] [Related]
13. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
[TBL] [Abstract][Full Text] [Related]
15. Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration.
You B; Liu Y; Chen J; Huang X; Peng H; Liu Z; Tang Y; Zhang K; Xu Q; Li X; Cheng G; Shi R; Zhang G
Cardiovasc Res; 2018 Jan; 114(1):188-199. PubMed ID: 29186367
[TBL] [Abstract][Full Text] [Related]
16. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
18. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
19. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]